Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study
| Autor: | Jermann, M., Jost, L.M., Taverna, Ch., Jacky, E., Honegger, H.P., Betticher, D.C., Egli, F., Kroner, Th., Stahel, R.A. * |
|---|---|
| Zdroj: | In Annals of Oncology March 2004 15(3):511-516 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|